India’s government is preparing a 30% trade-margin cap on 137 non-scheduled cancer medicines, with drug companies working toward a November 9, 2026 implementation deadline. The government expects cancer drug prices to fall, but healthcare experts warn that some costs could shift to other services.

Key Takeaways

  • The government estimates that maximum retail prices could fall by 20% to 70%, with annual savings of about ₹2,500 crore.
  • The 30% limit applies to trade margins; it is not a fixed 30% reduction in each medicine’s retail price.
  • Some hospital and advocacy voices are concerned that providers could recover costs through other charges.

How the cap could affect cancer drug prices

The cap is intended to affect medicines sold through chemists and hospitals. In an affidavit, the government said the proposed measure would reduce patients’ out-of-pocket spending and improve price transparency.

The government cited patients’ limited bargaining power and knowledge of medicines, substitutes and prices as reasons for regulation. Its estimated price reductions and savings are projections, not reported results.

The source does not specify the previous trade-margin rules for these medicines or a separate effective date. Sudarshan Jain of the Indian Pharmaceutical Alliance said companies were working on implementation by November 9 and would communicate price cuts to consumers.

Concern over costs elsewhere in treatment

Healthcare administrator N. Santhanam said the industry could absorb the cap but argued that affordability measures should also address expensive medicines in other therapeutic areas.

Hospital and industry representatives cautioned that providers might seek to recover costs through other services, including services that were not previously billed. That is a risk they identified, rather than a confirmed consequence of the new cap.

KM Gopakumar, co-convener of the Working Group on Access to Medicines and Treatments, said cancer drugs could remain expensive for patients needing multiple doses a month. He called for ceiling prices on other hospital services to prevent costs from shifting to areas such as diagnostics.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.